Literature DB >> 19733911

VDR and MEK-ERK dependent induction of the antimicrobial peptide cathelicidin in keratinocytes by lithocholic acid.

Mark Peric1, Sarah Koglin, Yvonne Dombrowski, Kathrin Gross, Eva Bradac, Thomas Ruzicka, Jürgen Schauber.   

Abstract

Cathelicidin is an antimicrobial peptide (AMP) and signaling molecule in innate immunity and a direct target of 1,25-dihydroxyvitamin D3 (1,25D3) in primary human keratinocytes (NHEK). The expression of cathelicidin is dysregulated in various skin diseases and its regulation differs depending on the epithelial cell type. The secondary bile acid lithocholic acid (LCA) is a ligand of the vitamin D receptor (VDR) and can carry out in vivo functions of vitamin D3. Therefore we analyzed cathelicidin mRNA- and peptide expression levels in NHEK and colonic epithelial cells (Caco-2) after stimulation with LCA. We found increased expression of cathelicidin mRNA and peptide in NHEK, in Caco-2 colon cells no effect was observed after LCA stimulation. The VDR as well as MEK-ERK signaled the upregulation of cathelicidin in NHEK induced by LCA. Collectively, our data indicate that cathelicidin induction upon LCA treatment differs in keratinocytes and colonic epithelial cells. Based on these observations LCA-like molecules targeting cathelicidin could be designed for the treatment of cutaneous diseases that are characterized by disturbed cathelicidin expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19733911     DOI: 10.1016/j.molimm.2009.08.010

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  10 in total

1.  PTH/PTHrP and vitamin D control antimicrobial peptide expression and susceptibility to bacterial skin infection.

Authors:  Beda Muehleisen; Daniel D Bikle; Carlos Aguilera; Douglas W Burton; George L Sen; Leonard J Deftos; Richard L Gallo
Journal:  Sci Transl Med       Date:  2012-05-23       Impact factor: 17.956

Review 2.  Vitamin D and the skin: Physiology and pathophysiology.

Authors:  Daniel D Bikle
Journal:  Rev Endocr Metab Disord       Date:  2012-03       Impact factor: 6.514

3.  Curcumin induces human cathelicidin antimicrobial peptide gene expression through a vitamin D receptor-independent pathway.

Authors:  Chunxiao Guo; Elena Rosoha; Malcolm B Lowry; Niels Borregaard; Adrian F Gombart
Journal:  J Nutr Biochem       Date:  2012-07-25       Impact factor: 6.048

4.  Synergistic induction of human cathelicidin antimicrobial peptide gene expression by vitamin D and stilbenoids.

Authors:  Chunxiao Guo; Brian Sinnott; Brenda Niu; Malcolm B Lowry; Mary L Fantacone; Adrian F Gombart
Journal:  Mol Nutr Food Res       Date:  2013-09-14       Impact factor: 5.914

Review 5.  Antimicrobial peptides and colitis.

Authors:  Samantha Ho; Charalabos Pothoulakis; Hon Wai Koon
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 6.  Regulation of antimicrobial peptide gene expression by nutrients and by-products of microbial metabolism.

Authors:  Yan Campbell; Mary L Fantacone; Adrian F Gombart
Journal:  Eur J Nutr       Date:  2012-07-15       Impact factor: 5.614

Review 7.  Gut Microbiota and Colonization Resistance against Bacterial Enteric Infection.

Authors:  Q R Ducarmon; R D Zwittink; B V H Hornung; W van Schaik; V B Young; E J Kuijper
Journal:  Microbiol Mol Biol Rev       Date:  2019-06-05       Impact factor: 11.056

8.  Vitamin D induction of the human antimicrobial Peptide cathelicidin in the urinary bladder.

Authors:  Olof Hertting; Åsa Holm; Petra Lüthje; Hanna Brauner; Robert Dyrdak; Aino Fianu Jonasson; Peter Wiklund; Milan Chromek; Annelie Brauner
Journal:  PLoS One       Date:  2010-12-14       Impact factor: 3.240

Review 9.  The Non-Genomic Actions of Vitamin D.

Authors:  Charles S Hii; Antonio Ferrante
Journal:  Nutrients       Date:  2016-03-02       Impact factor: 5.717

Review 10.  Xenobiotic Receptors and Their Mates in Atopic Dermatitis.

Authors:  Deborah Minzaghi; Petra Pavel; Sandrine Dubrac
Journal:  Int J Mol Sci       Date:  2019-08-29       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.